Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05041361 · ClinicalTrials.gov registry record · NA
HypErthermia as an Additional Treatment for the Biology and Experience of Depression
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT05041361 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 16 participants.
The verdict
NCT05041361, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This single-arm feasibility trial administered up to 8 weekly (early phase) or 4 bi-weekly (later phase) whole-body hyperthermia (WBH) sessions and 8 weekly cognitive behavioral therapy (CBT) sessions to adults aged 18 years or older with major depressive disorder (MDD).
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy (CBT)
- DEVICE Whole-Body Hyperthermia (WBH)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-10-11 |
| Est. Completion | 2023-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05041361
The ClinicalTrials.gov registry entry for NCT05041361 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavioral Therapy (CBT) is the first listed.
NCT05041361 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05041361 about?
NCT05041361 is a clinical study titled "HypErthermia as an Additional Treatment for the Biology and Experience of Depression". This single-arm feasibility trial administered up to 8 weekly (early phase) or 4 bi-weekly (later phase) whole-body hyperthermia (WBH) sessions and 8 weekly cognitive behavioral therapy (CBT) sessions to adults aged 18 years or older with major depressive disorder (MDD).
What is the current status of trial NCT05041361?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2021-10-11. Estimated completion is 2023-03-01.
What interventions are being tested in trial NCT05041361?
The interventions under investigation include: Cognitive Behavioral Therapy (CBT) (BEHAVIORAL), Whole-Body Hyperthermia (WBH) (DEVICE).
Who is sponsoring clinical trial NCT05041361?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.